Cartwheeling spider among new species

Sharon Begley|Published

About 18 000 species, great and small, were discovered in 2014, adding to the 2 million already known, scientists said.

'Home-brew' morphine now possible

Sharon Begley|Published

Scientists have engineered brewer's yeast to synthesise opioids such as codeine and morphine from a common sugar.

Women scientists get the nod - study

Sharon Begley|Published

When US college faculty members rated junior scientists, they preferred women over identically qualified men.

Stemcells from human embryos prove safe

Sharon Begley|Published

The longest-running trial of stemcells derived from a human embryo found that the cells caused patients none of the problems scientists feared.

Ebola waste disposal a thorny issue

Sharon Begley|Published

Few US hospitals are equipped with incinerators needed to safely handle contaminated items generated from the care of an Ebola patient.

Nobel Prize science predictions

Sharon Begley|Published

The predictions come from the Intellectual Property & Science unit of Thomson Reuters.

Happiness study draws frowns from critics

Sharon Begley|Published

High-profile 2013 happiness study is fatally flawed, according to new analysis.

Drug saves monkeys with Marburg fever

Sharon Begley|Published

An experimental drug helped lab monkeys recover from the most deadly strain of Marburg virus, a close cousin of Ebola.

How flu sample was tainted with deadly strain

Sharon Begley|Published

In CDC bird flu mix-up, US agency cites sloppy science and failed reporting.

Injecting bacteria shrinks cancer tumours

Sharon Begley|Published

Common soil bacteria injected into solid cancers in pet dogs and one human patient shrank many of the tumours, scientists reported.

‘Plantibodies' enter fight against Ebola

Sharon Begley|Published

Drugmakers' use of the tobacco plant as a cheap way to produce novel biotechnology treatments is gaining global attention.

E-cigarette researchers count puffs

Sharon Begley|Published

The FDA is spending $270-million on research projects to determine the risks of e-cigarettes.

What's in a (hurricane) name?

Sharon Begley|Published

People unconsciously think a storm with a female name is less dangerous and are less likely to flee, a new study shows.

The top 10 newly-discovered species

Sharon Begley|Published

Scientists believe nature holds another 10 million undiscovered species, from single-celled organisms to mammals.

Foreign doctors could take MERS global

Sharon Begley|Published

The biggest risk that Middle East Respiratory Syndrome will become a global epidemic may lie with globe-trotting healthcare workers.

How to take control of your dreams

Sharon Begley|Published

Nightmares in which you encounter an ax-wielding psychopath may become a thing of the past, thanks to a discovery.

The elixir of youth lies in blood?

Sharon Begley|Published

Making old brains and old muscles perform like young ones may require something as simple as a blood transfusion.

Cloned embryos yield stem cells for diabetes

Sharon Begley|Published

Two labs say they have created embryos by cloning cells of living people - and another says it has gone a step further.

Paralysed patients regain movement

Sharon Begley|Published

The success, albeit in a small number of patients, offers hope that a fundamentally new treatment can help many.

The crow that outsmarts a preschooler

Sharon Begley|Published

A species of crow, native to islands east of Australia, has long wowed scientists with its intelligence.

Outbreak: Nations come up with plan

Sharon Begley|Published

The Global Health Security Agenda aims to prevent epidemics by keeping to a minimum the number of labs that store dangerous microbes.

‘Vulcan mind meld’ just a publicity stunt?

Sharon Begley|Published

Scientists said they have achieved the first human-to-human mind meld by sending a brain signal via the Internet. [VIDEO]

Transparent brain promises to unlock mysteries

Sharon Begley|Published

A neuroscientist at Stanford University has invented a technique to make brains transparent.

‘Nightmare bacteria' shrugging off antibiotics

Sharon Begley|Published

Some Enterobacteriaceae have become resistant to all or almost all antibiotics, including last-resort drugs.

Genetic cancer drugs ‘not the Holy Grail’

Sharon Begley|Published

A new finding could explain why almost none of the new generation of “personalised” cancer drugs is a true cure.